Intersect ENT Competitors and Similar CompaniesClear all
Regeneron Pharmaceuticals's competitors and similar companies include OptiNose.
 Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. | ||
Founding Date | Founding Date 1988 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Morrisville, US HQ Oslo, NO Swindon, GB |
Employees | Employees 15,1068% increase | Employees 2048% decrease |
Valuation ($) | Valuation ($) 102.2 b | Valuation ($) 118.1 m |
Financial | ||
Revenue (est.) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $78.2m (FY, 2024) |
Net income | Net income $4.5b (FY, 2025) | Net income ($21.5m) (FY, 2024) |
Operating ⚠ | ||
Patents (US) | Patents (US) 31 (FY, 2020) | Patents (US) 43 (Jun, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 53.9m | Total funding raised $ 120.5m |
For sources of this data, please see the company profile
View Company Profiles
OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company